Revenue Performance - Revenue decreased by 13.6% to HKD 620.3 million compared to HKD 718.1 million in the same period last year, primarily due to reduced demand in Hong Kong and mainland China, as well as increased outbound travel affecting local retail consumption[13] - Revenue from Hong Kong accounted for 80.3% of total revenue, while revenue from outside Hong Kong accounted for 19.7%[17] - Revenue in mainland China decreased by 19.3% due to challenging business conditions, including a downturn in the real estate sector and weak consumer confidence[34] - The company's revenue for the six months ended September 30, 2024, was HK$620.27 million, a decrease from HK$718.15 million in the same period last year[56] - Revenue from Hong Kong decreased to HKD 497.8 million in the six months ended September 30, 2024, compared to HKD 549.6 million in the same period last year[111] - Revenue from regions outside Hong Kong (including China, Macau, Australia, and Singapore) decreased to HKD 122.5 million in the six months ended September 30, 2024, compared to HKD 168.5 million in the same period last year[111] - Total revenue for the six months ended September 30, 2024, was HKD 620.3 million, down from HKD 718.1 million in the same period last year[111] Business Segments and Strategy - Medical aesthetics business contributed 73.3% of total sales, while non-medical aesthetics accounted for the remaining 26.7%[13] - The company implemented a multi-format store strategy, including flagship stores and smaller community stores, to better serve customers in their local areas[11] - The company's "integrated service approach" strategy combines non-invasive medical aesthetics services with non-medical aesthetics services, such as hair loss treatment, pain management, and sleep therapy, to meet a broader range of consumer needs[11] - The company's "dual-cycle" strategy, focusing on both medical and non-medical aesthetic services, is expected to drive sustainable growth[49] - The company aims to expand its high-end service portfolio and network in key regions, including the introduction of VIP lounges in major centers to attract affluent clients[49] Cost Management and Expenses - Employee benefits expenses decreased by 8.6% to HKD 217.6 million, reflecting efforts to maintain efficiency and reduce indirect costs[22] - Marketing expenses decreased by 9.6% to HKD 77.2 million due to strategic reductions in promotional spending[22] - Rental and leasing-related expenses decreased by 8.4% to HKD 76.2 million, driven by favorable renegotiations and optimized use of store space[22] - Key cost components decreased by 10.7% to 470,473 thousand HKD compared to 526,841 thousand HKD in the previous period[25] - Inventory and consumables costs decreased by 20.8% to 10,492 thousand HKD from 13,248 thousand HKD[26] - Employee benefits expenses decreased by 8.6% to 217,604 thousand HKD from 238,149 thousand HKD[26] - Government subsidies decreased to 832 thousand HKD in 2024 from 3,549 thousand HKD in 2023[116] - Current tax expense in Hong Kong was 19,743 thousand HKD in 2024, down from 21,494 thousand HKD in 2023[123] - Depreciation expenses for right-of-use assets (properties) were HKD 56,088 thousand for the six months ended September 30, 2024, compared to HKD 62,511 thousand for the same period in 2023[156] - Total lease cash outflows were HKD 57,800 thousand for the six months ended September 30, 2024, down from HKD 63,457 thousand for the same period in 2023[158] Profitability and Financial Performance - EBITDA decreased by 19.9% to 193.9 million HKD, with an EBITDA margin of 31.3% compared to 33.7% in the previous period[27] - Operating profit decreased by 21.5% to 158.5 million HKD, with an operating profit margin of 25.6% compared to 28.1% in the previous period[27] - Net profit attributable to shareholders decreased by 15.4% to 140.8 million HKD, with a net profit margin of 22.7% compared to 23.2% in the previous period[27] - The company's operating profit for the six months ended September 30, 2024, was HK$158.48 million, down from HK$201.93 million in the previous year[55] - The company's net profit attributable to equity holders for the six months ended September 30, 2024, was HK$140.84 million, compared to HK$166.39 million in the same period last year[56] - Net profit for the six months ended September 30, 2024, was HK$131.34 million, compared to HK$166.39 million in the same period last year, representing a decrease of 21.1%[58] - Total comprehensive income for the period was HK$160.35 million, up from HK$142.50 million in the previous year, an increase of 12.5%[58] - Profit attributable to equity holders of the company was 140,844 thousand HKD in 2024, compared to 166,393 thousand HKD in 2023[125] Cash Flow and Financial Position - The company maintained a strong financial position with bank and cash balances of 479.6 million HKD as of September 30, 2024, and no external bank borrowings[35] - Capital expenditures for the six months ended September 30, 2024, totaled 26.1 million HKD, primarily used for leasehold improvements and equipment for service network expansion[36] - Cash and cash equivalents dropped significantly to HK$289.81 million from HK$567.40 million, a decrease of 48.9%[70] - Net cash generated from operating activities was HK$203.38 million, down from HK$288.02 million in the previous year, a decrease of 29.4%[81] - Net cash used in investing activities was HK$210.25 million, compared to net cash generated of HK$188.29 million in the prior year[81] - Net cash used in financing activities was HK$275.12 million, slightly lower than the HK$278.40 million used in the previous year[81] - Cash and cash equivalents totaled HKD 289,808 thousand as of September 30, 2024, a decrease from HKD 567,401 thousand as of March 31, 2024[141] Assets and Liabilities - Total assets decreased to HK$1,076.88 million from HK$1,221.81 million, a reduction of 11.8%[69] - Property, plant, and equipment decreased to HK$136.55 million from HK$146.98 million, a reduction of 7.1%[63] - Right-of-use assets declined to HK$227.17 million from HK$260.75 million, a decrease of 12.9%[64] - Non-current assets in Hong Kong decreased to HKD 329.0 million as of September 30, 2024, compared to HKD 397.5 million as of March 31, 2024[115] - Non-current assets in regions outside Hong Kong increased to HKD 73.2 million as of September 30, 2024, compared to HKD 50.9 million as of March 31, 2024[115] - Total non-current assets decreased to HKD 402.3 million as of September 30, 2024, compared to HKD 448.5 million as of March 31, 2024[115] - Lease liabilities decreased to HKD 238,697 thousand as of September 30, 2024, from HKD 268,726 thousand as of March 31, 2024[153] - Trade payables increased to HKD 1,541 thousand as of September 30, 2024, from HKD 1,070 thousand as of March 31, 2024[161] - Capital commitments for property, plant, and equipment decreased to HKD 954 thousand as of September 30, 2024, from HKD 2,312 thousand as of March 31, 2024[162] Shareholder Information and Dividends - The company's basic earnings per share for the six months ended September 30, 2024, was 11.2 HK cents, down from 13.2 HK cents in the previous year[56] - The company declared an interim dividend of 11.2 HK cents per share and a special dividend of 0.1 HK cents per share for 2024[129] - The company proposed an interim dividend of 11.2 HK cents per share and a special dividend of 0.1 HK cents per share for the six months ended September 30, 2024[168] - The company will suspend share registration from December 16, 2024, to December 17, 2024, and shareholders must submit transfer documents by December 13, 2024, to be eligible for the interim dividend[170] - Basic earnings per share were 11.2 HK cents in 2024, down from 13.2 HK cents in 2023[125] Investments and Financial Instruments - The company held significant investments in listed equity securities, including an 80,000-share investment in a consumer-to-business platform, representing 0.0015% of the total equity, with a fair value of HK$13.76 million as of September 30, 2024[43] - Dividend income from financial assets at fair value through other comprehensive income was 1,160 thousand HKD in 2024, down from 1,247 thousand HKD in 2023[116] - Net exchange gain was 669 thousand HKD in 2024, compared to a net exchange loss of 289 thousand HKD in 2023[119] - Net financial income decreased to 1,442 thousand HKD in 2024 from 1,834 thousand HKD in 2023[120] - The weighted average effective interest rate for time deposits with original maturities exceeding three months was 3.48% as of September 30, 2024[135] - The weighted average effective interest rate for pledged bank deposits was 2.93% as of September 30, 2024, compared to 2.66% as of March 31, 2024[140] Employee and Operational Metrics - The company employed a total of 1,161 employees as of September 30, 2024, a decrease from 1,273 employees as of March 31, 2024[45] - The company plans to integrate AI-driven customer service tools into its operations to provide 24/7 automated customer support, aiming to enhance customer engagement and satisfaction[50] - The company is committed to sustainability, with efforts to reduce carbon emissions and implement sustainable practices in its facilities[52] - Total service area across Hong Kong and other regions reached 318,000 square feet as of September 30, 2024[16] - The company expanded its community store network in Hong Kong, increasing total service area to approximately 202,000 square feet, despite a 9.4% decline in overall revenue[30] Shareholder Structure and Governance - As of September 30, 2024, Dr. Ouyang Jiang holds 114,834,747 ordinary shares, representing 75.08% of the company's total shares[177] - Sure Sino Investments Limited holds 459,739,481 ordinary shares, representing 36.59% of the company's total shares[187] - Earlson Holdings Limited holds 208,306,511 ordinary shares, representing 16.58% of the company's total shares[187] - Perfect Medical Charity Foundation Limited holds 159,123,029 ordinary shares, representing 12.66% of the company's total shares[187] - Dr. Ouyang Jiang holds a 54.65% beneficial interest in Sure Sino Investments Limited[180] - Ms. Ouyang Hong holds a 22.68% beneficial interest in Sure Sino Investments Limited[180] - Ms. Ouyang Hui holds a 22.67% beneficial interest in Sure Sino Investments Limited[180] - The total number of shares issued by the company as of September 30, 2024, is 1,256,197,771[188] - No other major shareholders hold more than 5% of the company's shares or related interests as of September 30, 2024[190] - The total number of share options available for issuance under the Share Option Plan as of April 1, 2024, and September 30, 2024, is 114,090,339[191] - The closing price of the shares immediately before the grant date (December 11, 2023) was HKD 3.260[196] - The share options granted on December 12, 2023, will vest on the first anniversary of the grant date (December 12, 2024) with no performance targets attached[197] - The total number of share options held by key individuals as of September 30, 2024, is 3,768,000[193] - The company did not purchase, sell, or redeem any of its listed securities during the six months ended September 30, 2024[198] - The company's Articles of Association and Cayman Islands law do not contain provisions regarding pre-emptive rights[199] - The company has not separated the roles of Chairman and CEO, with Dr. Ouyang Jiang holding both positions, which the board believes is beneficial for the company's business prospects and management[200]

Financial Performance - Revenue decreased by 13.6% to HKD 620.3 million[3] - Profit attributable to equity holders decreased by 15.4% to HKD 140.8 million[3] - Basic earnings per share were HKD 11.2 cents[3] - Operating profit was HKD 158.5 million, down from HKD 201.9 million[5] - Total comprehensive income for the period was HKD 160.3 million, compared to HKD 142.5 million in the previous year[7] - EBITDA decreased by 19.9% to HKD 193.9 million, with an EBITDA margin of 31.3%, down from 33.7% in the previous year[69] - The net financial income for the six months ended September 30, 2024, was HKD 1,442,000, compared to HKD 1,834,000 in the same period of 2023[28] - The total income tax expense for the six months ended September 30, 2024, was HKD 28,576,000, a decrease of 23.5% from HKD 37,374,000 in the same period of 2023[30] - Basic earnings per share for the six months ended September 30, 2024, was HKD 11.2, down from HKD 13.2 in the same period of 2023, reflecting a decrease of 15.2%[33] Dividends - Proposed interim dividend and special dividend of HKD 11.2 cents and HKD 0.1 cents, total dividend of HKD 11.3 cents[3] - Dividend payout ratio was 100.9%, maintaining over 100% for ten consecutive years[3] - The company proposed a mid-term dividend of HKD 13.2 per share, totaling HKD 165,810,000, and a special dividend of HKD 1.0 per share, totaling HKD 12,513,000[35] - The group plans to pay an interim dividend of HKD 0.112 per share and a special dividend of HKD 0.001 per share[70] - The board proposed an interim dividend of HKD 0.112 per share and a special dividend of HKD 0.001 per share, to be paid on or around December 31, 2024[93] Assets and Liabilities - Total assets decreased to HKD 1,076.9 million from HKD 1,221.8 million[9] - Cash and cash equivalents decreased to HKD 289.8 million from HKD 567.4 million[9] - Non-controlling interests decreased to HKD 452.2 million from HKD 497.5 million[11] - Non-current assets in Hong Kong totaled HKD 329,040,000, down from HKD 397,502,000 as of March 31, 2024[24] - Non-current assets outside Hong Kong amounted to HKD 73,224,000, an increase from HKD 50,974,000[24] - As of September 30, 2024, the total equity amounted to HKD 321,246 thousand, down from HKD 389,081 thousand on April 1, 2024, reflecting a decrease of approximately 17.4%[46] - The company's net book value of property, plant, and equipment as of September 30, 2024, was HKD 136,550,000, down from HKD 151,275,000 as of September 30, 2023[38] - Trade payables as of September 30, 2024, totaled HKD 1,541 thousand, an increase from HKD 1,070 thousand as of March 31, 2024, reflecting a rise of about 43.8%[52] Revenue Breakdown - Revenue from Hong Kong was HKD 497,803,000, down 9.4% from HKD 549,616,000 in the previous year[21] - Revenue from regions outside Hong Kong was HKD 122,469,000, a decrease of 27.3% from HKD 168,533,000 in the prior year[21] - Revenue from mainland China decreased by 19.3%, impacted by a sluggish business environment and weak consumer confidence[76] - The medical beauty business contributed 73.3% of total sales, while non-medical beauty accounted for the remaining portion[66] - Average spending per medical beauty service customer dropped by 36.6% to HKD 17,243, reflecting a shift towards more value-for-money options[66] - The overall average spending per individual customer decreased by 26.2% to HKD 20,311[66] Operational Highlights - The group expanded its service area in Hong Kong to approximately 202,000 square feet by adding two new locations in strategic areas[72] - Employee benefits expenses fell by 8.6% to HKD 217.6 million, indicating efforts to maintain efficiency and reduce indirect costs[68] - The group continues to focus on optimizing its market presence in Australia and Singapore despite facing challenges from high inflation and reduced consumer spending[76] - The company is adopting a cautious approach to market fluctuations by implementing various store formats, including flagship and small community stores, to better serve customers[60] - The integrated service approach combines non-invasive medical beauty services with non-medical beauty services, aiming to meet a broader range of consumer needs and preferences[61] Cash Flow and Financial Position - As of September 30, 2024, the group's cash and bank balance was HKD 479.6 million, down from HKD 575.3 million as of March 31, 2024, with no external bank borrowings[77] - The net cash generated from operating activities during the period was HKD 203.4 million, compared to HKD 288.0 million in the previous fiscal year[77] - Capital expenditures for the six months ended September 30, 2024, totaled HKD 26.1 million, primarily for lease renovations and equipment to expand the service network[78] - The company maintains a strong financial position with a debt-to-equity ratio of zero as of September 30, 2024[77] Governance and Compliance - The company has complied with all provisions of the Corporate Governance Code during the reporting period, except for the separation of roles between the Chairman and CEO[116] - The Audit Committee, established on December 5, 2011, reviewed the unaudited interim results for the six months ended September 30, 2024[118] - The Remuneration Committee is responsible for recommending remuneration policies for all directors and senior management, including compensation for loss of office[119] - The Nomination Committee evaluates the independence of independent non-executive directors and reviews board diversity policies[121] - The company emphasizes strong leadership by having the same individual serve as both Chairman and CEO, which is believed to benefit business management[116] - The board of directors includes both executive and independent non-executive members, ensuring a diverse governance structure[122] Future Outlook - The management highlighted the ongoing economic challenges, including high interest rates and inflation, impacting consumer confidence and retail performance in Hong Kong[59] - The group anticipates gradual improvement in business fundamentals and customer spending in the coming months, barring unforeseen external factors[89] - The company is committed to sustainability and aims to create a positive environmental and social impact while enhancing brand reputation[92] - The company plans to integrate AI-driven customer service tools into operations to enhance customer engagement and satisfaction[90]

Financial Performance - The company reported a revenue of HKD 1,393.3 million for the fiscal year ending March 31, 2024, representing a 0.3% increase from HKD 1,389.3 million in the previous year[11]. - Operating profit decreased by 3.5% to HKD 382.4 million compared to HKD 396.1 million in the prior year[11]. - The profit attributable to equity holders was HKD 315.8 million, a slight increase of 0.1% from HKD 315.6 million in the previous year, with a net profit margin of 22.7%[11][16]. - The company reported a sales contract price of HKD 1,446.4 million, a year-on-year decrease of 0.3%, while revenue increased by 0.3% to HKD 1,393.3 million[29]. - The company’s revenue for the fiscal year 2024 reached HKD 1,393.3 million, a slight increase from HKD 1,389.3 million in the previous year, driven by a recovery in consumer spending and contributions from new stores in Hong Kong and mainland China[30]. - Revenue from Hong Kong operations increased by 4.0% to HKD 1,081.4 million, accounting for 77.6% of total revenue, compared to 74.9% in the previous year[38]. - Revenue from regions outside Hong Kong decreased by 10.7% year-on-year to HKD 311.9 million, accounting for 22.4% of total revenue[43]. - The company reported a total comprehensive income of HKD 271,861,000 for the year, down from HKD 300,585,000 in 2023, a decrease of 9.6%[173]. - The company incurred a net other comprehensive loss of HKD 38,538,000 for the year, compared to a loss of HKD 15,053,000 in the previous year[173]. Assets and Liabilities - Total assets as of March 31, 2024, were HKD 1,221.8 million, down from HKD 1,296.3 million in the previous year[9]. - The total liabilities increased to HKD 725.0 million from HKD 684.0 million in the previous year, indicating a rise in financial obligations[9]. - Total equity decreased to HKD 496,808,000 in 2024 from HKD 612,273,000 in 2023, a decline of 19%[175]. - Total liabilities increased to HKD 725,004,000 in 2024 from HKD 684,021,000 in 2023, representing a growth of 6.1%[176]. - The total equity and liabilities decreased to HKD 1,221,812,000 in 2024 from HKD 1,296,294,000 in 2023, a decline of 5.8%[176]. Store Expansion and Market Presence - The company opened 11 new stores in Hong Kong, including two flagship stores and nine community stores, to expand its market presence[18]. - The company opened a total of 11 new stores in Hong Kong, including 2 flagship stores and 9 community stores, to expand its market presence and enhance customer convenience[26]. - The company successfully opened four new stores in mainland China and Macau, contributing to revenue growth driven by post-pandemic consumer recovery[44]. - The company aims to enhance brand awareness and market share in the fragmented beauty market in mainland China through strategic store deployments[44]. Operational Efficiency and Strategy - The company aims to enhance operational efficiency and customer engagement through AI-driven marketing initiatives[15]. - The company is focused on enhancing operational efficiency and promoting innovation as part of its future growth strategy[24]. - The group plans to implement a "dual circulation" strategy to enhance growth and profitability in the medical and non-medical beauty services sectors[51]. - The group is strategically expanding into profitable new locations based on geographic data and consumer behavior analysis[52]. - The group aims to achieve sustainable growth through key initiatives focused on increasing revenue and profitability, including targeted marketing campaigns[54]. Dividends and Shareholder Returns - The company proposed a total dividend of HKD 31.5 cents per share for the year, representing a total payout ratio of 125.5%[36]. - The board proposed a final and special dividend of HKD 11.9 cents and HKD 5.4 cents per share, respectively, subject to shareholder approval[56]. - The total annual dividend for the year ending March 31, 2024, will amount to HKD 31.5 cents per share[56]. - The company paid dividends totaling HKD 391,934,000 in 2024, up from HKD 191,785,000 in 2023, indicating an increase of 104.5%[179]. Corporate Governance - The board consists of four executive directors and three independent non-executive directors as of March 31, 2024[71]. - Dr. Ouyang Jiang serves as both the Chairman and CEO, which the board believes provides strong and consistent leadership[69]. - The company has established an audit committee, remuneration committee, and nomination committee in compliance with corporate governance codes[69]. - The company has adhered to the corporate governance code for the year ending March 31, 2024, with one exception regarding the separation of roles between the Chairman and CEO[69]. - The company has a clear structure for delegating authority to management while retaining approval rights for significant strategic decisions[80]. Risk Management and Internal Controls - The company has implemented a risk management framework since 2016, following the COSO model to effectively manage various risks[102]. - The audit committee conducted an annual review of the risk management and internal control systems, confirming their effectiveness[100]. - The company has established internal controls for handling and disclosing inside information in compliance with regulations[101]. - The company’s risk management activities are continuously conducted by management, with at least one annual assessment of the effectiveness of the risk management framework[103]. Employee and Management Information - As of March 31, 2024, the group employed a total of 1,273 employees, a decrease from 1,317 employees as of March 31, 2023[50]. - The board emphasizes the importance of employee development and competitive compensation to retain high-quality staff[118]. - The company has established a share option plan, allowing participants to acquire equity, aligning their interests with the group's benefits[126]. Environmental and Social Responsibility - The company has deposited HKD 265.9 million in green deposits to support environmentally friendly projects, reflecting its commitment to sustainable development[49]. - The company has implemented environmental policies and measures to promote sustainability in its operations[117]. - The group emphasizes the importance of sustainable development and social responsibility in its operations[55]. Financial Reporting and Compliance - The financial statements are prepared in accordance with Hong Kong Financial Reporting Standards and the Companies Ordinance[181]. - The company adopted new accounting standards without significant impact on its financial policies and statements[182]. - The company has changed its accounting policy regarding long service payments, which may lead to adjustments in past service costs[184]. - The company recognizes financial assets on the trade date, which is when the company commits to purchase or sell the asset[196].

完美医疗240702 ...

完美医疗 20240702_原文 2024年07月02日 21:48 发言人 00:00 首先我们上周五的时候公布了我们全年的业绩。刚才陈总也说过了，我们业绩应该是还可以，特别是香港 跟国内的大网点又不是太好的时候，很所有人都以为我们利润有可能有一点压力，有可能派出比例也有一 点压力，都没有。我现在分开两个部分说一下，今天有可能今天黄安那边有也好，投资人也好，有可能想 问一下我们对整个香港跟国内的社会市场怎么样去看，我们之后会说这个一事情。不过首先让我过一下去 年的业绩，因为有些事情在业绩里面不能说太多，也不能写太多出来。所以我自己算一下最后的一个部分 就是往后一两年2526财年到底我们会怎么样去做，去应对这个香港国内这么困难的环境，我们到底要做 什么？有些事情是今年会新的，所以也要特别跟国内的投资者说明一下，这个事情好过一下。去年的叶子 你们都已经看过了，所以我不会说太多。 发言人 01:10 不过去年我们差不多做了14亿港币的收益，其实拆开来看的话，我们矛盾在香港，矛盾在整个大中华地区， 包括国内，包括澳门。其实我们的收益也能做到一个单位数字的提升，一个单位数字其实我们香港以外的 地区有一点下跌的压力。去 ...

我是华音乐团队的分析师沈嘉蔚又一同三星的还有我们的首席团队乔老师首先的话还是希望说公司的老公司在整体消费跟经济还能够比较全然的情况下还能够取得在开明一个稳定增长的业绩包括我们看到的是RCMA经济率以及超百分之百的一个排斥比率整体的无论是经营还是财务指标都非常的亮眼 那我们其实今天也是很荣幸请到了公司的高管团队然后去跟我们做交流那首先我还是想把时间交还给公司的这个LG Peter来帮我们去对R&D的一些包括对R&D的一个展望做一个回顾Peter好的 谢谢陈总谢谢各位投资者我是完美技能的投资官Peter今天跟我一起来的有我们的老板欧阳总跟我们的CFOMarco总 首先我们上周五的时候公布了我们全面的业绩刚才陈总也说过了我们业绩应该是还可以吧特别是香港跟国内的大环境又不是太好的时候很多人就以为我们中内院有可能有一点压力有可能派出比例也有一点压力都没有啊 我先分开两个部分说一下,今天有可能,今天华安那边也好,投资人也好,有可能想问一下我们对整个香港跟国内的社会市场怎么去看,我们之后会说这个事情。不过,首先让我过一下去年的页字,因为有些事情在页字里面不能说太多,也不能写太多出来,所以我自己说一下。 最后的一个部分,就是 ...

今天跟我一起来的有我们的老板欧阳总跟我们的CFO马口总首先我们上周五的时候公布了我们全面的业绩刚才陈总也说过了我们业绩应该是还可以吧特别是香港跟国内的大环境又不是太好的时候很多人就以为我们中内院有可能有一点压力有可能派出比例也有一点压力都没有啊 我先分开栏的部分说一下今天有可能今天华安那边也好投资人也好有可能想问一下我们对整个香港跟国内的社会市场怎么去看我们之后会说这个事情不过首先让我过一下去年的业绩因为有些事情在业绩里面不能说太多吧你不能写太多出来所以我自己说一下 最後的一個部分就是往後一兩年二五二六財年到底我們會怎麼去做去應對這個香港啊國內這麼困難的環境啊我們到底要做什麼有些事情是今年會新的所以也要特別跟國內的投資者說明一下這個事情好過一下去年的業績你們都已經看過了所以我不會說太多 不過去年我哋差唔多做咗14億港幣嘅收益。其實拆開嚟睇嘅話,我哋無論喺香港,無論喺整個大中華地區,包括國內,包括澳門,其實我哋嘅收益也能做到一個單位數字嘅提升。一個單位數字。其實我哋香港以外嘅地區有一點下跌嘅壓力,去年下跌10%, 只是因为新加坡跟欧大利亚的影响,两边都挺困难的。如果没有这两个地区的话,其实我们整个香港跟中国内地 ...

香港交易及結算所有限公司及香港聯合交易所有限公司（「聯交所」）對本公佈的內容概不 負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公佈全部或任何 部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 PERFECT MEDICAL HEALTH MANAGEMENT LIMITED 完美醫療健康管理有限公司 （於開曼群島註冊成立之有限公司） （股份代號：1830） 截至二零二四年三月三十一日止年度 全年業績公佈 | --- | --- | |-------|----------------------------------------------------------------------------------------------------| | | | | 摘要 | | | • | 收益上升 0.3% 至 1,393.3 百萬港元。 | | • | 扣除利息、稅項以及物業、廠房及設備折舊前盈利下降 4.4% 至 461.3 百萬港元。 | | • | 本公司權益持有人應佔利潤（不計及香港政府補助）增加 6.8% 至 315.8 百萬港元。 | | • | 每股基本盈利維持 ...

Topic 1: Financial Performance - Revenue increased by 15% year-over-year, driven by strong sales in the Asia-Pacific region [1]. - Net profit margin improved to 12%, up from 10% in the previous quarter [2]. - Operating expenses rose by 8%, primarily due to increased marketing and R&D investments [3]. Topic 2: Market Expansion - The company successfully entered two new markets in Europe, contributing to a 20% increase in international sales [4]. - A new distribution center was opened in South America to support regional growth [5]. - Strategic partnerships were formed with local retailers in Southeast Asia to enhance market penetration [6]. Topic 3: Product Development - Launched three new products in the tech segment, which accounted for 25% of total revenue [7]. - R&D spending increased by 10% to accelerate innovation and product differentiation [8]. - Customer feedback on the new product line has been overwhelmingly positive, with a 90% satisfaction rate [9]. Topic 4: Operational Efficiency - Implemented a new ERP system, reducing operational costs by 5% [10]. - Streamlined supply chain processes, resulting in a 15% reduction in delivery times [11]. - Employee training programs were expanded, leading to a 20% improvement in productivity [12]. Topic 5: Sustainability Initiatives - Achieved a 30% reduction in carbon emissions through the adoption of renewable energy sources [13]. - Launched a recycling program that has successfully recycled 50% of the company's waste [14]. - Committed to achieving net-zero emissions by 2030, with interim targets set for 2025 [15]. Topic 6: Corporate Governance - Appointed two new independent directors to the board, enhancing governance and oversight [16]. - Implemented a new whistleblower policy to ensure ethical practices across the organization [17]. - Conducted annual audits with no material findings, reinforcing the company's commitment to transparency [18].

香港交易及結算所有限公司及香港聯合交易所有限公司（「聯交所」）對本公告的內容概不 負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何 部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 PERFECT MEDICAL HEALTH MANAGEMENT LIMITED 完美醫療健康管理有限公司 （於開曼群島註冊成立之有限公司） （股份代號：1830） 截至二零二三年九月三十日止六個月 中期業績公告 | --- | --- | |-------|------------------------------------------------------------------------------------------------| | | | | | 摘要 | | • | 收益增加 7.5% 至 718.1 百萬港元。 | | • | 除稅後純利增加 10.4% 至 166.4 百萬港元。倘不計及香港政府補助，經修訂除稅後 純利增加 27.1% 。 | | • | 每股基本盈利增加 9.1% 至 13.2 港仙。 | | • | 建議中期股息及特別股息為每股 13.2 ...